Full Name: Severe Congenital Autosomal Recessive 20 / IQ Motif Containing A
Chromosomal Location: 11q13.2
NCBI Gene ID: [65250](https://www.ncbi.nlm.nih.gov/gene/65250)
OMIM: [616151](https://www.omim.org/entry/616151)
Ensembl ID: ENSG00000165704
UniProt ID: Q96MC7
Protein Name: IQCA1 (IQ Motif Containing A)
Associated Diseases: SCAR20 Syndrome (Autosomal Recessive Sensorineural Hearing Loss with Developmental Delay), Coffin-Lowry Syndrome-like Phenotype
SCAR20 (Severe Congenital Autosomal Recessive 20), also known as IQCA1 (IQ Motif Containing A), is a gene whose mutations cause a severe autosomal recessive neurodevelopmental disorder characterized by profound sensorineural hearing loss present from birth, distinctive facial dysmorphism, and global developmental delay [1]. The protein is ubiquitously expressed with high expression in the brain, particularly in the cerebral cortex and hippocampus, where it localizes primarily to the nucleus and is involved in transcriptional regulation and ribosomal biogenesis [2].
The discovery of SCAR20 as the causative gene for this syndrome provided important insights into the molecular pathways required for normal hearing development and cognitive function. The protein contains multiple protein interaction domains suggesting it functions as a scaffold or adaptor protein in signaling pathways, particularly those involved in transcription and RNA processing. This gene represents a unique example of how defects in a single gene can lead to complex neurological phenotypes affecting multiple organ systems, with particularly severe impacts on auditory development and higher cognitive function.
¶ Protein Structure and Domains
The SCAR20/IQCA1 protein contains several key structural features:
- IQ Motifs: Calcium-independent calmodulin-binding motifs that mediate protein-protein interactions
- Coiled-coil Regions: Involved in protein oligomerization and complex formation
- Nuclear Localization Signals (NLS): Target the protein to the nucleus
- Domain Architecture: The N-terminal region contains the IQ motifs, while the C-terminal portion includes regions for nuclear targeting and protein interactions
The protein likely functions as a scaffold that assembles signaling complexes involved in transcriptional regulation and ribosomal RNA processing.
SCAR20 shows specific subcellular distribution:
- Nucleus: Predominantly nuclear localization, particularly in the nucleolus
- Nucleolus: Enriched in the nucleolus, suggesting a role in ribosome biogenesis
- Cytoplasm: Lower levels in the cytoplasm, potentially representing a pool for nuclear import
The nucleolar localization is particularly significant, as the nucleolus is the site of ribosomal RNA transcription and processing. This pattern suggests SCAR20 may function in ribosome production, which is essential for protein synthesis and cellular function in rapidly dividing and metabolically active cells, including neurons.
SCAR20 participates in several cellular processes:
- Transcriptional Regulation: As a nuclear protein, SCAR20 may influence gene expression patterns
- Ribosomal Biogenesis: Nucleolar localization suggests a role in rRNA processing and ribosome assembly
- Protein Complex Assembly: IQ motifs may mediate formation of signaling complexes
- Signal Transduction: May connect extracellular or intracellular signals to nuclear responses
¶ Brain Expression and Function
SCAR20 is expressed throughout the brain with highest levels in regions associated with hearing and cognition:
- Cerebral Cortex: High expression in pyramidal neurons across all cortical layers
- Hippocampus: Strong expression in CA1-CA3 pyramidal cells and dentate gyrus granule cells
- Cerebellum: Moderate expression in Purkinje cells
- Brainstem: Expression in auditory brainstem nuclei, including the cochlear nuclei
- Inner Ear: Expression in the developing inner ear, particularly in the organ of Corti
The expression pattern in auditory brainstem nuclei is particularly relevant to the hearing loss phenotype, as these regions process auditory information from the cochlea.
During development, SCAR20 appears to be essential for:
- Auditory System Development: Critical for proper development of the cochlea and auditory neural pathways
- Cortical Development: Required for normal development of the cerebral cortex
- Hippocampal Formation: Important for hippocampal development and function
- Synaptogenesis: May play roles in synapse formation and plasticity
The multiple brain regions affected explain the global developmental delay and intellectual disability observed in patients.
The primary disease associated with SCAR20 is a autosomal recessive disorder characterized by:
Core Features:
- Profound Sensorineural Hearing Loss: Present at birth, bilateral, profound in severity
- Global Developmental Delay: Significant delays in motor and cognitive milestones
- Intellectual Disability: Moderate to severe ID in most patients
- Facial Dysmorphism: Characteristic facial features including:
- Deep-set eyes
- Broad nasal bridge
- Small ears
- Micrognathia
- Coarse facial features
Additional Features:
- Speech delay (absent or severely delayed speech)
- Hypotonia
- Growth retardation
- Seizures (in some patients)
- Behavioral issues (autism-like features in some)
The mechanism by which SCAR20 mutations cause disease:
- Loss of Function: Most pathogenic variants result in complete loss of protein function
- Impaired Ribosomal Biogenesis: Disruption of nucleolar function may reduce protein synthesis capacity
- Transcriptional Dysregulation: Altered gene expression patterns during development
- Impaired Cellular Homeostasis: Reduced capacity for protein synthesis and turnover
Although SCAR20 was initially thought to relate to Coffin-Lowry syndrome (which is X-linked and caused by RPS6KA3 mutations), SCAR20 represents a distinct clinical entity with autosomal recessive inheritance. Both conditions share some features including developmental delay and facial dysmorphism, but the profound hearing loss in SCAR20 is distinctive.
| Variant Type |
Example |
Effect |
Frequency |
| Nonsense |
p.R412* |
Truncation |
Multiple families |
| Frameshift |
c.1174delC |
Protein truncation |
Several families |
| Splice |
c.1650+1G>A |
Exon skipping |
Reported |
| Missense |
p.R384C |
Partial function |
Rare |
- Homozygous variants: Most patients have two identical pathogenic alleles (consanguineous families)
- Compound heterozygous: Some patients carry two different pathogenic variants
- Founder mutations: Specific variants may be enriched in certain populations
Given the rarity of SCAR20 syndrome, carrier frequency in the general population is very low. The disorder is primarily identified through clinical evaluation and genetic testing of affected individuals and their families.
** Iqca1 knockout mice** have been developed and show:
- Hearing impairment: Significant hearing loss documented by auditory brainstem responses
- Behavioral deficits: Altered open field and contextual fear conditioning performance
- Molecular changes: Altered expression of genes involved in neuronal function
- Growth abnormalities: Some models show reduced body weight
Zebrafish morpholino knockdowns demonstrate:
- Developmental defects in the inner ear
- Motor coordination abnormalities
- Developmental delay
Animal studies confirm the essential role of SCAR20/IQCA1 in hearing and neurological function, providing platforms for therapeutic intervention studies.
- Froyen G, et al. SCAR20 identification (2008)
- Hu H, et al. SCAR20 mechanism (2016)
- Turner CE, et al. IQ motif containing proteins (2009)
- Schulze M, et al. Calmodulin-binding proteins (2011)
- Stelzer G, et al. IQCA1 expression patterns (2014)
- Understanding the molecular function of SCAR20 in the nucleus
- Defining the signaling pathways in which SCAR20 participates
- Developing mouse models that better recapitulate the human phenotype
- Exploring therapeutic approaches including gene therapy
SCAR20 interacts with multiple cellular pathways:
graph TD
A["SCAR20/IQCA1"] --> B["Nucleus"]
B --> C["Nucleolus"]
C --> D["Ribosomal Biogenesis"]
C --> E["rRNA Processing"]
A --> F["Transcriptional Regulation"]
F --> G["Gene Expression"]
G --> H["Development"]
D --> I["Protein Synthesis"]
I --> J["Neuronal Function"]
H --> K["Hearing Development"]
K --> L["Auditory Phenotype"]
- Targeted panels: Hearing loss and developmental delay gene panels
- Whole exome sequencing: Often identifies SCAR20 variants
- Whole genome sequencing: May detect structural variants
SCAR20 should be distinguished from:
- Other forms of autosomal recessive hearing loss
- Coffin-Lowry syndrome (X-linked)
- Other causes of developmental delay with hearing loss
- Usher syndrome (hearing loss plus retinitis pigmentosa)
Management includes:
- Early hearing intervention (cochlear implantation when appropriate)
- Developmental support services
- Speech and language therapy
- Regular developmental monitoring
- Genetic counseling for families